Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02831959 : Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
PhasePhase 3
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

1. 18 years of age and older

2. Life expectancy of ? 3 months

3. New diagnosis of brain metastases from a histologically or cytologically confirmed
primary or metastatic NSCLC tumor within 5 years of registration on the study. If the
original histological proof of malignancy is greater than 5 years, then pathological
confirmation is required (i.e.: from extra-cranial or intracranial disease).

4. Karnofsky performance status (KPS) ? 70

5. Graded Prognostic Assessment (GPA) score ? 2.0

6. 1 inoperable brain metastasis or 2- 10 brain lesions per screening MRI, confirmed by
contrast enhanced MRI amenable to SRS according to the following criteria:

1. largest tumor volume < 10 cc

2. longest tumor diameter < 3 cm

3. Cumulative volume of all tumors ? 15 cc

7. At least one measurable lesion per RANO-BM (Response Assessment in Neuro-Oncology
Brain Metastases) Criteria for brain metastasis

8. Patients must be receiving optimal therapy for their extracranial disease according to
local practice at each center. Patients may continue on systemic therapy while
receiving TTFields.

9. Able to operate the NovoTTF-100M device independently or with the help of a caregiver

10. Clinical trials prior to enrollment are allowed, as long as no brain directed therapy
was included (current treatment trials are exclusionary)

Exclusion Criteria:

1. Patients who are known to have somatic tumor mutations in the following genes, for
which targeted agents are available that directly affect the treatment of brain
metastasis: Anaplastic lymphoma kinase (ALK), epidermal growth factor receptor (EGFR),
ROS-1 proto-oncogene, and proto-oncogene B-RAF

2. Patients who have a single, operable brain metastasis

3. Patients with significant edema leading to risk of brain herniation

4. Patients with midline shift > 10mm

5. Patients with intractable seizures

6. Infratentorial metastases

7. Leptomeningeal metastases

8. Recurrent brain metastases or brain metastases previously treated with surgery and/or
radiosurgery and/or brain radiotherapy

9. Prior surgical resection or WBRT for newly diagnosed brain metastases (needle biopsy
for diagnosis establishment is allowed)

10. Severe comorbidities:

1. Clinically-significant inadequate hematological, hepatic and renal function,
defined as: Neutrophil count < 1.5 x 10 9/L and platelet count < 100 x 10^9/L;
bilirubin > 1.5 x upper limit of normal (ULN); aspartate transaminase (AST)
and/or alanine aminotransferase (ALT) > 2.5 x ULN or > 5 x ULN if patient has
documented liver metastases; and serum creatinine > 1.5 x ULN

2. History of significant cardiovascular disease unless the disease is well
controlled. Significant cardiac disease includes second/third degree heart block;
significant ischemic heart disease; poorly controlled hypertension; congestive
heart failure of the New York Heart Association (NYHA) Class II or worse (slight
limitation of physical activity; comfortable at rest, but ordinary activity
results in fatigue, palpitation or dyspnea).

3. History of arrhythmia that is symptomatic or requires treatment. Patients with
atrial fibrillation or flutter controlled by medication are not excluded from
participation in the trial.

4. History of cerebrovascular accident (CVA) within 6 months prior to randomization
or that is not stable

5. Active infection or serious underlying medical condition that would impair the
ability of the patient to received protocol therapy

6. History of any psychiatric condition that might impair patient's ability to
understand or comply with the requirements of the study or to provide consent

11. Implantable electronic medical devices in the brain

12. Known allergies to medical adhesives or hydrogel

13. Currently pregnant or breastfeeding

14. Concurrent brain directed therapy (beyond SRS and NovoTTF-100M as per protocol)
LinksPermanent Link to THIS page: http://virtualtrials.com/nct/display1trial.cfm?nct=NCT02831959      |      Link to official Clinicaltrials.gov listing
Locations
Winnipeg, Manitoba
Canada

Facility: Cancercare Manitoba
Investigator: Saranya Kakumanu, MD
Contact:
Email not avaialable

Montreal, Quebec
Canada

Facility: Notre-Dame Hospital CHUM
Investigator: David Roberge, MD
Contact: Diane Trudel, RN Phone: 514-890-8000
Email not avaialable

Montreal, Quebec
Canada

Facility: Jewish General Hospital
Investigator: Thierry Muanza, MD
Contact: Thierry Muanza Phone: (514)-340-8288
Click HERE to send email to this center

Montréal, Quebec
Canada

Facility: Le CIUSSS de I'Est-de-L'ile de Montreal
Investigator: Pierre Chabot, MD
Contact: Veronique Tran Phone: (514)-252-3400
Click HERE to send email to this center

Sherbrooke, Quebec
Canada

Facility: Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke (CIUSSS de l'Estrie - CHUS)
Investigator: David Mathieu, MD
Contact: Anick Champoux Phone: (819)-346-1110
Click HERE to send email to this center

Birmingham, Alabama
Facility: University of Alabama at Birmingham Comprehensive Cancer Center
Investigator: John Fiveash, MD
Contact: Melissa Deakle
Click HERE to send email to this center

Phoenix, Arizona
Facility: Mayo Clinic Phoenix
Investigator: Terence Sio, MD
Contact: Terence Sio, MD Phone: 855-776-0015
Click HERE to send email to this center

Tucson, Arizona
Facility: University of Arizona Cancer Center
Investigator: Hani Babiker, MD
Contact: Crystal Placencia Phone: 520-694-1231
Click HERE to send email to this center

Los Angeles, California
Facility: Keck Medical Center of USC
Investigator: Thomas Chen, MD
Contact: Sandy Leong Phone: 323-442-7532
Click HERE to send email to this center

Los Angeles, California
Facility: Cedars-Sinai Medical Center
Investigator: Jethro Hu, MD
Contact: Jaime Richardson, RN Phone: 310-423-2133
Click HERE to send email to this center

Orange, California
Facility: Chao Family Comprehensive Cancer Center
Investigator: Jose Carrillo, MD
Contact: Jinah Chung Phone: 877-827-8839
Click HERE to send email to this center

Orange, California
Facility: The Center for Cancer Prevention and Treatment at St. Joseph Hospital of Orange
Investigator: Venita Williams, MD
Contact: Martha French Phone: 714-734-6200
Click HERE to send email to this center

Redwood City, California
Facility: Kaiser Permanente Redwood City
Investigator: Scott Peak, MD
Contact: Nancy Mendelssohn, CCRC Phone: 650-299-4165
Click HERE to send email to this center

Sacramento, California
Facility: Kaiser Permanente - Sacramento
Investigator: Enrico Lallana, MD
Contact: Renee Cunanan Phone: 916-973-4885
Click HERE to send email to this center

Fairfield, Connecticut
Facility: Associated Neurologists of Southern CT
Investigator: Nicholas Blondin, MD
Contact: Micah Sy Phone: 203-333-1151
Click HERE to send email to this center

Gainesville, Florida
Facility: University of Florida
Investigator: David Tran, MD
Contact: Sarah Andrews, RN Phone: 352-273-7981
Click HERE to send email to this center

Miami, Florida
Facility: Miami Cancer Institute
Investigator: Minesh Mehta, MD
Contact: Jessica Gonzalez-Salas Phone: 786-527-8112
Click HERE to send email to this center

Atlanta, Georgia
Facility: Piedmont Brain Tumor Center
Investigator: Adam Nowlan, MD
Contact: Shirley Elkins Phone: 404-605-2050
Click HERE to send email to this center

Chicago, Illinois
Facility: Robert H. Lurie Comprehensive Cancer Center - Northwestern University
Investigator: Priya Kumthekar, MD
Contact: Rachel Lukas Phone: 312-695-1371
Click HERE to send email to this center

Maywood, Illinois
Facility: Loyola University Medical Center
Investigator: Abhishek Solanki, MD
Contact: Beth Chiappetta Phone: 708-216-2568
Click HERE to send email to this center

Warrenville, Illinois
Facility: CDH-Delnor Health System
Investigator: Vinai Gondi, MD
Contact: Donald Smith, MS, CCRC Phone: 603-352-5360
Click HERE to send email to this center

Edgewood, Kentucky
Facility: St. Elizabeth Healthcare Cancer Care Center
Investigator: Robert Albright, MD
Contact: Darla Hehman, RN Phone: 859-301-5473
Click HERE to send email to this center

Louisville, Kentucky
Facility: University of Louisville
Investigator: Eric Burton, MD
Contact: Erika Hargis Phone: 502-217-5244
Click HERE to send email to this center

New Orleans, Louisiana
Facility: Tulane Cancer Center
Investigator: Steven DiBiase, MD
Contact: Elise M Tatje Phone: 504-988-6121
Click HERE to send email to this center

New Orleans, Louisiana
Facility: Ochsner Health System
Investigator: Marcus Ware, MD, PhD
Contact: Jessica Henry Phone: 504-842-8769
Click HERE to send email to this center

Boston, Massachusetts
Facility: Tufts Medical Center
Investigator: Suriya Jeyapalan, MD
Contact: Leanne Ianniello Phone: 617-636-2883
Click HERE to send email to this center

Boston, Massachusetts
Facility: Beth Israel Deaconess Medical Center
Investigator: Eric Wong, MD
Contact: Christina Ng Phone: 617-667-1832
Click HERE to send email to this center

Troy, Michigan
Facility: 21st Century Oncology
Investigator: Vito John Antonucci, MD
Contact: Paulette Palazzolo Phone: 248-672-7745
Click HERE to send email to this center

Minneapolis, Minnesota
Facility: John Nasseff Neuroscience Institute ANW Brain Tumor Center
Investigator: John Trusheim, MD
Contact: Meghan Hultman Phone: 612-863-3308
Click HERE to send email to this center

Minneapolis, Minnesota
Facility: Masonic Cancer Clinic
Investigator: Emil Lou, MD
Contact: Kim Sieckowski Phone: 612-626-4495
Click HERE to send email to this center

Rochester, Minnesota
Facility: Mayo Clinic
Investigator: Daniel Ma, MD
Contact: Justin Buroker Phone: 507-293-0624
Click HERE to send email to this center

New York, New York
Facility: Weil Cornell Medical College/New York Presbyterian Hospital
Investigator: Ronald Scheff, MD
Contact: Amanda De Laurentiis Phone: 646-962-9349
Click HERE to send email to this center

New York, New York
Facility: Icahn School of Medicine at Mount Sinai
Investigator: Isabelle Germano, MD
Contact: Johnny Chan Phone: 212-824-7861
Click HERE to send email to this center

New York, New York
Facility: Nyph/Cumc
Investigator: Teri Kreisl, MD
Contact: David Cieremans Phone: 212-304-5570
Click HERE to send email to this center

Winston-Salem, North Carolina
Facility: Wake Forest Health
Investigator: Michael Chan, MD
Contact: Shirley Coe Phone: 336-713-6505
Click HERE to send email to this center

Cleveland, Ohio
Facility: Cleveland Clinic
Investigator: Manmeet Ahluwalia, MD
Contact: Manmeet Ahluwalia, MD Phone: 216-444-6145
Email not avaialable

Danville, Pennsylvania
Facility: Geisinger Medical Center
Investigator: Scott Turner, MD
Contact: Angela Whitmire Phone: 570-214-2834
Click HERE to send email to this center

Philadelphia, Pennsylvania
Facility: Hospital of the University of Pennsylvania
Investigator: Steven Brem, MD
Contact: Scott Levy Phone: 215-662-6832
Click HERE to send email to this center

Providence, Rhode Island
Facility: Rhode Island Hospital
Investigator: Alexander Mohler, MD
Contact: Wendy Turchetti, RN Phone: 401-444-7698
Click HERE to send email to this center

Germantown, Tennessee
Facility: West Cancer Center
Investigator: Matthew Ballo, MD
Contact: Rachel Adams, CCRP Phone: 910-683-0055
Click HERE to send email to this center

Austin, Texas
Facility: Texas Oncology - Austin
Investigator: Morris Groves, MD
Contact: Kristen Brueggemann Phone: 512-421-4100
Click HERE to send email to this center

Houston, Texas
Facility: The University of Texas M.D. Anderson Cancer Center
Investigator: Jing Li, MD
Contact: Bobby Korah Phone: 713-745-8308
Click HERE to send email to this center

Lubbock, Texas
Facility: Joe Arrington Cancer Research and Treatment Center
Investigator: Paul Anderson, MD
Contact: Sonia Salas Phone: 806-725-8068
Click HERE to send email to this center

Temple, Texas
Facility: Baylor Scott & White Health
Investigator: Ekokobe Fonkem, MD
Contact: Dedra Preece, CRC Phone: 254-771-4826
Click HERE to send email to this center

Charlottesville, Virginia
Facility: University of VA Health Sciences Center
Investigator: Jason Sheehan, MD
Contact: Joe Farrar, BS Phone: 434-982-6455
Click HERE to send email to this center

Norfolk, Virginia
Facility: Sentara Health
Investigator: Wylie Zhu, MD
Contact: Rebecca M Lee Phone: 757-388-4393
Click HERE to send email to this center

Milwaukee, Wisconsin
Facility: Aurora Research Institute - St. Luke's Medical Center
Investigator: George Bobustuc, MD
Contact: Kate McPolin Phone: 414-385-7125
Click HERE to send email to this center




Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites